Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple-Ascending Doses of BGB-16673 in Adults With Chronic Spontaneous Urticaria [Phase 1]

View source ↗

Summary

Phase 1 study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple-ascending doses of BGB-16673 in adults with chronic spontaneous…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Urticaria

Drugs mentioned

• BGB-16673

Snippet

Sponsor: BeiGene | Conditions: Chronic Spontaneous Urticaria | Phase 1 | Status: ACTIVE_NOT_RECRUITING